Get the Stockscreener App
1.89
1.05%
-0.02
After Hours:
1.89
Seer Inc stock is traded at $1.89, with a volume of 121.31K.
It is down -1.05% in the last 24 hours and up +2.72% over the past month.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
See More
Previous Close:
$1.91
Open:
$1.88
24h Volume:
121.31K
Relative Volume:
0.81
Market Cap:
$106.32M
Revenue:
$14.18M
Net Income/Loss:
$-82.66M
P/E Ratio:
-1.4538
EPS:
-1.3
Net Cash Flow:
$-50.80M
1W Performance:
-3.08%
1M Performance:
+2.72%
6M Performance:
-10.85%
1Y Performance:
-18.18%
1-Day Range:
$1.85
$1.9192
1-Week Range:
$1.85
$1.9899
52-Week Range:
$1.62
$2.438
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.89 | 107.44M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Hedge Fund Moves: Does Seer Inc meet Warren Buffetts criteriaOptions Play & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Strategic Environmental & Energy Resources, Inc. SEC 10-Q Report - TradingView — Track All Markets
Aug Patterns: Why Seer Inc stock remains on buy listsTrade Analysis Summary & Risk Adjusted Buy/Sell Alerts - Bộ Nội Vụ
Seer, Inc. (NASDAQ:SEER) Sees Large Decrease in Short Interest - MarketBeat
Published on: 2026-01-10 22:18:34 - Улправда
Why Seer Inc. stock could benefit from AI revolutionOptions Play & Community Consensus Trade Signals - Улправда
Growth Review: Why Seer Inc. stock is a must watch in 2025Risk Management & Community Consensus Trade Alerts - Улправда
Why Seer Inc. stock is a must watch in 2025Weekly Stock Analysis & Expert Curated Trade Setup Alerts - Улправда
Is Seer Inc. stock gaining market shareEarnings Growth Summary & Free Weekly Watchlist of Top Performers - ulpravda.ru
The Truth About Seer Inc: Is This ‘Future of Biotech’ Stock Secretly on Clearance? - AD HOC NEWS
Will Seer Inc. stock benefit from sector rotation2026 world cup usa national team round of 32 goalkeepers low block defense odds analysis expert opinion - Улправда
Seer (NASDAQ:SEER) Trading 1.1% HigherHere's Why - MarketBeat
Seer (NASDAQ:SEER) Trading 1.1% Higher – Here’s Why - Defense World
We Think Seer (NASDAQ:SEER) Can Afford To Drive Business Growth - Yahoo Finance
Seer (SEER) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
How Seer Inc. stock performs after earningsJuly 2025 Rallies & Stock Market Timing Techniques - Улправда
Will Seer Inc. stock benefit from AI adoption2025 Historical Comparison & Technical Entry and Exit Alerts - Улправда
Can Seer Inc. stock deliver strong Q4 earningsJuly 2025 Drop Watch & Breakout Confirmation Alerts - Улправда
Seer to Report First Quarter 2025 Financial Results on May 13, 2025 - 富途牛牛
Analyst Calls: Will Seer Inc. stock benefit from sector rotationEarnings Recap Report & Low Volatility Stock Recommendations - Улправда
What catalysts could drive Seer Inc. stock higherSell Signal & AI Driven Price Forecasts - DonanımHaber
Stock Market Recap: How Seer Inc. stock performs after earningsMarket Risk Report & Daily Entry Point Alerts - Улправда
Wall Street Recap: Why Seer Inc. stock could benefit from AI revolutionDividend Hike & Weekly Momentum Stock Picks - Улправда
Insider Trends: Will Seer Inc. stock benefit from AI adoptionQuarterly Earnings Summary & Real-Time Buy Signal Notifications - Улправда
Retail Trends: Will Seer Inc. stock benefit from sector rotationJuly 2025 Momentum & Safe Capital Growth Stock Tips - Улправда
Aug Drivers: Is Seer Inc stock a buy before product launches2025 Winners & Losers & Community Verified Swing Trade Signals - moha.gov.vn
Seer (NASDAQ:SEER) Shares Down 2.8%Here's What Happened - MarketBeat
Seer (NASDAQ:SEER) Shares Down 2.8% – Here’s What Happened - Defense World
Wall Street Zen Upgrades Seer (NASDAQ:SEER) to Hold - MarketBeat
Seer (NASDAQ: SEER) ends dual-class shares as Class B converts to Class A - Stock Titan
Seer, Inc. (SEER) director reports 4,088-share Class B to A conversion - Stock Titan
Aug Retail: How buybacks impact Seer Inc stock valueMarket Growth Summary & Weekly High Return Stock Forecasts - moha.gov.vn
How Seer Inc. stock trades during market volatilityQuarterly Growth Report & Accurate Intraday Trading Signals - Newser
What drives Seer Inc stock priceStochastic Oscillator Alerts & Budget Friendly Trading Alerts - earlytimes.in
Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers - markets.businessinsider.com
Seer (SEER) Utilizes Proteograph Suite in Groundbreaking Genetic Study - GuruFocus
Seer, Inc. Publishes Landmark Genome-Wide Association Study Validating Mass Spectrometry Proteomics in Nature Genetics - Quiver Quantitative
Nature Genetics Study Validates Seer’s Proteograph Platform - GlobeNewswire
Aug Retail: Is Seer Inc. stock gaining market share2025 Price Targets & Scalable Portfolio Growth Methods - Bộ Nội Vụ
Seer, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:SEER) 2025-11-26 - Seeking Alpha
Saskatchewan’s Blake and Melanie Berglund giving local artists a leg up with new label - CTV News
What Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now? - MSN
Seer Inc Stock Analysis and ForecastPrice Support Zones & Free Trend Following Techniques - earlytimes.in
Pres Horn Surrenders 6,797 Of Seer Inc [SEER] - TradingView
[Form 4] Seer, Inc. Insider Trading Activity - Stock Titan
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way - Investing.com India
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way By Investing.com - Investing.com Canada
What insider trading reveals about Seer Inc. stockWeekly Investment Summary & High Conviction Buy Zone Alerts - newser.com
Key metrics from Seer Inc.’s quarterly data2025 Momentum Check & Smart Money Movement Tracker - newser.com
Can Seer Inc. stock sustain market leadershipQuarterly Earnings Report & High Conviction Buy Zone Alerts - newser.com
Predicting Seer Inc. trend using moving averages2025 Trading Recap & Technical Entry and Exit Alerts - newser.com
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.73%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):